Rood Buys Shares as Mnts Stock Targets $10 Million
mnts stock surged nearly 20% in overnight trading ahead of Tuesday after recent insider purchases and a $10 million revenue target pushed Momentus into the center of another rapid move. For traders in a thinly traded name, that left a short-term squeeze in price tied to filings, guidance, and fresh space-sector attention.
John Rood’s $10 Million Target
John Rood said on May 5 that Momentus was targeting $10 million in revenue this year, a ninefold increase from $1.1 million in 2025. He also said the company had raised $5 million in a private placement and had become debt-free, giving the market a clearer set of operating markers to trade against.
Rood’s shareholder letter said, “Momentus enters the remainder of 2026 with a fully operational spacecraft on-orbit, a sold-out next mission, a strengthened balance sheet, active contracts with the nation’s top defense agencies, and a facility built to scale.” He added, “We are not a company waiting for an opportunity to arrive. We are actively executing towards it — mission by mission, contract by contract.”
Five Executives Bought Shares
Last week, securities filings showed that Rood, CTO Rob Schwarz, CFO Lon Ensler, legal chief Jon Layman, and board member Brian Kabot all acquired shares of Momentus. That kind of insider buying gave the move an additional catalyst after the company’s own revenue target had already put a number on management’s expectations.
Nearly 20% overnight upside followed a week in which mnts stock added 35.4% overall. Last Thursday, the shares had already surged over 21% after SpaceX disclosed confidentially submitting its IPO paperwork, and early Tuesday sentiment on Stocktwits was described as extremely bullish. For a micro-cap company, that sequence left little room for passive trading; orders were chasing a fast-moving name with a narrow float and a fresh narrative.
Vigoride 7 and 2027
Momentus is a space infrastructure company focused on orbital transportation, and its main product is the Vigoride Orbital Service Vehicle. Vigoride 7 launched on SpaceX’s Transporter-16 mission in March and is currently operating with payloads for NASA and the U.S. Air Force, while Vigoride 8 is planned for 2027 and has already completed its Preliminary Design Review.
Vigoride 8 is already fully booked with NASA-backed payloads, and Momentus is also developing in-space servicing and orbital assembly technologies under NASA- and DARPA-linked programs. If the company can turn the $10 million target into recurring contract revenue, the trading backdrop suggests the stock may keep reacting sharply to each filing, mission update, or new contract milestone rather than to broad space-sector sentiment alone.
